Koji Kubono

The title compound, [Zn ₂ (C ₂₂ H ₁₈ ClN ₄ O) ₂ ](ClO ₄ ) ₂ ·CH ₃ CN, consists of one centrosymmetric cationic dinuclear zinc(II) complex with two pentadentate ligands containing quinolin-8-olato and bis(pyridin-2-ylmethyl)amine groups, two perchlorate counter-ions and one acetonitrile solvate molecule. The Zn ^II atom adopts a distorted octahedral geometry and coordinates the O atom and the N atom of the quinolin-8-olato group and three N atoms of the bis(pyridin-2-ylmethyl)amine group in a ligand, and the O atom in an adjacent ligand generated by an inversion operation. The phenolato oxygen atoms in the two ligands of the cationic dinuclear complex are bridging coordinated with the two Zn ^II atoms. In the crystal, the cationic dinuclear complex molecules and perchlorate ions are linked by C—H...Cl and C—H...O hydrogen bonds, forming a three-dimensional network.

The asymmetric unit of the title compound is composed of one host molecule, anti-4-(1⁹ H,5⁹ H-3-aza-1,5(3,9)-dicarbazolacyclooctaphane-3-yl)benzonitrile and one dichloromethane solvate molecule, C₃₆H₂₈N₄·CH₂Cl₂. The host molecule possesses a planar chirality but crystallizes as a racemate in the space group P2₁/c. It adopts an anti-configuration, in which two carbazole rings are partially overlapped with a parallel orientation. The two carbazole ring systems are slightly bent, and the C atoms at the 3- and 1-positions show the largest deviations from the mean planes. The dihedral angle between two carbazole rings is 9.42 (3)°, forming an intramolecular parallel π–π interaction [Cg...Cg = 3.2755 (9) Å]. In the crystal, the molecules are linked via host–host and host–guest C—H...π interactions, forming chain structures along the a-axis direction. The molecules are linked into a ribbon structure along the c-axis direction by further C—H...π interactions. As a result, The molecules are cross-linked by C—H...π interactions into a three-dimensional network.

The title compound, [Zn₂(C₂₂H₁₈ClN₄O)Cl₃], is a dinuclear zinc(II) complex with three chlorido ligands and one pentadentate ligand containing quinolin-8-olato and bis(pyridin-2-ylmethyl)amine groups. One of the two Zn^II atom adopts a tetrahedral geometry and coordinates two chlorido ligands with chelate coordination of the N and O atoms of the quinolin-8-olato group in the ligand. The other Zn^II atom adopts a distorted trigonal–bipyramidal geometry, and coordinates one chlorido-O atom of the quinolin-8-olato group and three N atoms of the bis(pyridin-2-ylmethyl)amine unit. In the crystal, two molecules are associated through a pair of intermolecular C—H...Cl hydrogen bonds, forming a dimer with an R ₂ ²(12) ring motif. Another intermolecular C—H...Cl hydrogen bond forms a spiral C(8) chain running parallel to the [010] direction. The dimers are linked by these two intermolecular C—H...Cl hydrogen bonds, generating a ribbon sheet structure in ac plane. Two other intermolecular C—H...Cl hydrogen bonds form a C(7) chain along the c-axis direction and another C(7) chain generated by a d-glide plane. The molecules are cross-linked through the four intermolecular C—H...Cl hydrogen bonds to form a three-dimensional network.

The asymmetric unit of the title compound is composed of two independent ion pairs of 4-(dimethylamino)pyridin-1-ium 8-hydroxyquinoline-5-sulfonate (HDMAP⁺·HqSA⁻, C₇H₁₁N₂ ⁺·C₉H₆NO₄S⁻) and neutral N,N-dimethylpyridin-4-amine molecules (DMAP, C₇H₁₀N₂), co-crystallized as a 1:1:1 HDMAP⁺:HqSA⁻:DMAP adduct in the monoclinic system, space group Pc. The compound has a layered structure, including cation layers of HDMAP⁺ with DMAP and anion layers of HqSA⁻ in the crystal. In the cation layer, there are intermolecular N—H...N hydrogen bonds between the protonated HDMAP⁺ molecule and the neutral DMAP molecule. In the anion layer, each HqSA⁻ is surrounded by other six HqSA⁻, where the planar network structure is formed by intermolecular O—H...O and C—H...O hydrogen bonds. The cation and anion layers are linked by intermolecular C—H...O hydrogen bonds and C—H...π interactions.